Tags

Type your tag names separated by a space and hit enter

Is there a link between seropositivity to Helicobacter pylori and hepatitis A virus? A systematic review.
Int J Infect Dis. 2010 Jul; 14(7):e567-71.IJ

Abstract

BACKGROUND

Since hepatitis A virus (HAV) is acquired primarily through the fecal-oral pathway, several investigators have used HAV seropositivity as a proxy for exposure to this pathway. This paper is a critical review of the evidence relevant to the association between seropositivity to HAV and Helicobacter pylori, and considers the validity of comparisons for testing the hypothesis that H. pylori spreads by the fecal-oral route.

MATERIALS AND METHODS

A Medline search identified reports of all types published in the English language literature that were linked to the keywords 'Campylobacter pylori', 'hepatitis A', or 'Helicobacter pylori', cross-referenced with 'seroepidemiology', 'seroprevalence', or 'seropositivity'. Studies identified by the search were included in the review if they used specific IgG antibodies to classify the serostatus of subjects for both HAV and H. pylori infection and provided an estimate of the magnitude of the association between HAV and H. pylori or information that permitted calculation of an odds ratio (OR).

RESULTS

Out of the 21 studies identified, 15 met the inclusion criteria. The studies showed ORs for an association of HAV and H. pylori that ranged from 0.81 to 8.4. After adjustment for potential confounders, ORs shifted toward the null. They also showed that HAV seroprevalence is lower than H. pylori seroprevalence in early life and then becomes higher in later life. Thus in most populations, the trends cross over at some point.

CONCLUSION

The observed associations between the two infections are generally overestimated by the confounding effects of age and socio-economic status-related factors, and when these factors are controlled, the association becomes weak. Moreover, HAV infection elicits a long-term antibody response, while H. pylori infection does not. Consequently, serostatus comparison does not constitute a convincing test of the fecal-oral transmission hypothesis for H. pylori.

Authors+Show Affiliations

Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia. abinsaid@ksu.edu.sa

Pub Type(s)

Journal Article
Review
Systematic Review

Language

eng

PubMed ID

20060352

Citation

BinSaeed, Abdulaziz A.. "Is There a Link Between Seropositivity to Helicobacter Pylori and Hepatitis a Virus? a Systematic Review." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, vol. 14, no. 7, 2010, pp. e567-71.
BinSaeed AA. Is there a link between seropositivity to Helicobacter pylori and hepatitis A virus? A systematic review. Int J Infect Dis. 2010;14(7):e567-71.
BinSaeed, A. A. (2010). Is there a link between seropositivity to Helicobacter pylori and hepatitis A virus? A systematic review. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 14(7), e567-71. https://doi.org/10.1016/j.ijid.2009.09.003
BinSaeed AA. Is There a Link Between Seropositivity to Helicobacter Pylori and Hepatitis a Virus? a Systematic Review. Int J Infect Dis. 2010;14(7):e567-71. PubMed PMID: 20060352.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Is there a link between seropositivity to Helicobacter pylori and hepatitis A virus? A systematic review. A1 - BinSaeed,Abdulaziz A, Y1 - 2010/01/13/ PY - 2009/04/20/received PY - 2009/08/29/revised PY - 2009/09/06/accepted PY - 2010/1/12/entrez PY - 2010/1/12/pubmed PY - 2010/9/29/medline SP - e567 EP - 71 JF - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases JO - Int J Infect Dis VL - 14 IS - 7 N2 - BACKGROUND: Since hepatitis A virus (HAV) is acquired primarily through the fecal-oral pathway, several investigators have used HAV seropositivity as a proxy for exposure to this pathway. This paper is a critical review of the evidence relevant to the association between seropositivity to HAV and Helicobacter pylori, and considers the validity of comparisons for testing the hypothesis that H. pylori spreads by the fecal-oral route. MATERIALS AND METHODS: A Medline search identified reports of all types published in the English language literature that were linked to the keywords 'Campylobacter pylori', 'hepatitis A', or 'Helicobacter pylori', cross-referenced with 'seroepidemiology', 'seroprevalence', or 'seropositivity'. Studies identified by the search were included in the review if they used specific IgG antibodies to classify the serostatus of subjects for both HAV and H. pylori infection and provided an estimate of the magnitude of the association between HAV and H. pylori or information that permitted calculation of an odds ratio (OR). RESULTS: Out of the 21 studies identified, 15 met the inclusion criteria. The studies showed ORs for an association of HAV and H. pylori that ranged from 0.81 to 8.4. After adjustment for potential confounders, ORs shifted toward the null. They also showed that HAV seroprevalence is lower than H. pylori seroprevalence in early life and then becomes higher in later life. Thus in most populations, the trends cross over at some point. CONCLUSION: The observed associations between the two infections are generally overestimated by the confounding effects of age and socio-economic status-related factors, and when these factors are controlled, the association becomes weak. Moreover, HAV infection elicits a long-term antibody response, while H. pylori infection does not. Consequently, serostatus comparison does not constitute a convincing test of the fecal-oral transmission hypothesis for H. pylori. SN - 1878-3511 UR - https://www.unboundmedicine.com/medline/citation/20060352/Is_there_a_link_between_seropositivity_to_Helicobacter_pylori_and_hepatitis_A_virus_A_systematic_review_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1201-9712(09)00361-0 DB - PRIME DP - Unbound Medicine ER -